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cardiac energy metabolism [1] . Mitochondrial oxidative phosphorylation (OXPHOS) is essential to provide the energy for cardiac function. The OXPHOS system essentially comprises the electron trans-1. Introduction port chain (complexes I to IV) and the F F ATP synthase 1 0 (complex V). These five protein complexes, located in the Idiopathic dilated cardiomyopathy (IDC) is a severe inner mitochondrial membrane, are constituted by a multicondition that results in heart enlargement and impairment tude of subunits, whose genes are distributed over both of the ventricular contractile function. It causes progressive nuclear and mitochondrial DNA (mtDNA). congestive heart failure that, in some patients, eventually
Recently, mtDNA defects have been found in an inrequires cardiac transplantation. The precise mechanisms creasing number of cases of IDC. These abnormalities leading to ventricular dilatation and dysfunction are not include the presence of specific point mutations in mitowell understood; however, during the last few years chondrial tRNAs (mtRNAs) and structural genes, as well attention has been focused on abnormalities of contractile as single large or multiple deletions [2] [3] [4] [5] [6] . Although in some cases a correlation between molecular defects and a decrease in specific mitochondrial enzymatic activities has been found, few studies focused on the characterisation of spectrophotometrically (UVIKON 922 Spectrophotometer, the respiratory chain function and the results have often Kontron, Switzerland). A total of 5-13 mg of protein was been contradictory. This could be due, in part, to the used to determine the activity of each complex, except for difficulties in interpreting enzymatic results on autopsied complex IV, for which we used 2.5 mg of protein. Assays hearts, or on the small fragments of myocardial tissue that were performed at 378C in 1 ml of medium according to can be obtained by means of heart biopsy. Moreover, the Rustin et al. [7] and Chretien et al. [8] . Protein was question of whether alterations in mtDNA sequence and determined according to Bradford [9] . enzymatic defects play a primary or secondary role in IDC remains essentially unanswered.
2.2.1. Measurement of the rotenone-sensitive NADHThe objective of the present study was to assess electron decylubiquinone oxidoreductase (complex I) transport chain function in mitochondria from cardiac
The assay was performed at 340 nm using the acceptor muscle of patients suffering from IDC undergoing heart 2,3-dimethoxy-5-methyl-6-n-decyl- II) years) were studied. Control groups were six patients with
The assay was performed at 600 nm using as acceptor ischemic heart disease (six men, ages 51 to 60 years) also (80 mM) DCPIP and 10 mM succinate as the donor in a undergoing cardiac transplantation because of cardiac medium containing 10 mM KH PO (pH 7.8), 2 mM 2 4 failure, and 17 organ donors (12 men and five women, EDTA, 1 mg / ml BSA in the presence of 80 mM 2,3-ages 29 to 77 years) who died due to craneoencephalic dimethoxy-5-methyl-6-n-decyl-1,4-benzoquinone, 0.24 traumatism or stroke, who had no history of heart disease, mM KCN, 4 mM rotenone, 0.2 mM ATP and 0.4 mM and whose heart was not suitable for transplantation, antimycin for 2 min. The addition of 10 mM malonate mainly due to lack of an appropriate receptor.
inhibited the oxidation of succinate. All patients undergoing cardiac transplantation were in heart failure class IV of the New York Heart Association 2.2.3. Measurement of ubiquinol cytochrome c reductase (NYHA) classification. Patients or their families gave (complex III) written consent, the protocol was approved by the ethical
The assay was performed at 550 nm using 40 mM committee of our Institution, and conforms with the oxidized cytochrome c as the acceptor and 80 mM principles outlined in the Declaration of Helsinski.
decylubiquinol as the donor in a medium containing 10 Ventricular transmural biopsies were obtained from the mM KH PO (pH 7.8), 1 mg / ml BSA, 2 mM EDTA, in 2 4 explanted heart during cardiac transplantation. Samples the presence of 0.24 mM KCN, 4 mM rotenone, 0.2 mM weighting 3-5 g were collected on phosphate buffer saline ATP for 2 min. The addition of 1 mM antimycin allowed and immediately stored in liquid nitrogen until further us to distinguish between the reduction of cytochrome c analysis.
catalyzed by the complex III and the nonenzymatic reduction of cytochrome c by the reduced quinone. 2.2. Spectrophotometrical studies 2.2.4. Measurement of the rotenone-sensitive NADHHomogenates from frozen heart muscle specimens were cytochrome c oxidoreductase (NCCR) (complex I1III) prepared in 30:1 vol of 0.25 M sucrose, 40 mM potassium
The assay was performed at 550 nm using 40 mM chloride, 2 mM ethylene glycol-bis(b-aminoethyl ether) oxidized cytochrome c as the acceptor and 0.8 mM NADH N,N,N9,N9-tetraacetic acid, 1 mg / ml bovine serum albumin as the donor in a medium consisting in 10 mM Tris (pH (BSA) and 20 mM Tris-HCl (pH 7.2). Tissues were 8.0) containing 1 mg / ml BSA and 0.4 mM KCN for 3 disrupted by seven strokes at 800 rpm in a glass-PTFE min. The addition of 4 mM rotenone allowed us to quantify potter. The homogenate was centrifuged at 2000 g for 8
the NCCR rotenone-sensitive activity. min. The pellet was discarded and the supernatant was used for biochemical studies.
2.2.5. Measurement of cytochrome c oxidase (complex The measurement of the specific activity of the in-IV) dividual complexes of the respiratory chain was performed
The assay was performed at 550 nm using 10 mM Total DNA was isolated from heart muscle tissue from three IDC patients whose complex III activity was below Table 1 . All patients with IDC and IC had NYHA class IV the normal control range and three controls. Standard congestive heart failure and were treated with vasodilators, procedures based on phenol-chloroform purification and digoxin and diuretics. None of the subjects studied had any isopropanol precipitation were used [11] . Sequencing of current infection or immunological disease. IDC patients the mitochondrial cyt b gene was performed on polyhad angiographically normal coronary arteries in all cases. merase chain reaction (PCR) amplified fragments. A 1378
There were no other differences in clinical variables or base pair mtDNA region (nucleotides 14 682 to 16 060) treatment between IDC and IC patients. containing the gene coding for cyt b was amplified by PCR by using the primers corresponding to mtDNA positions 3.2. OXPHOS activities 14 682-14 709 and 16 060-16 048. DNA fragments were purified from agarose gels by the Qiagen purification kit Specific activities of complex I, complex II, complex III, (Qiagen, Chatsworth, CA, USA), and automatically secomplex IV, complex I1III and CS in IDC, IC patients and quenced using 3.5 pmols of sequencing primers and a Taq controls are presented in Table 2 . Dye DeoxyE Terminator Sequencing kit (No. 401 113;
Complexes II, III and I1III activities in heart homogeApplied Biosystems, Foster City, CA, USA) according to nates of both, IDC and IC patients, were significantly the manufacturer's recommendations. Data analyses were lower than those of healthy controls. There were no performed with the Collection and Analysis computer differences for the rest of enzyme activities. programs from Applied Biosystems. Cyt b gene sequences In order to exclude the possible influence of the number from patients and controls were compared with the Camof mitochondria, the enzyme activities of the different bridge mtDNA sequence [12] .
complexes were corrected by CS activity (Table 3 ). While the difference of complex II activity disappeared, the 2. 4 . Statistics values of complex III activity remained significantly lower in IDC and IC patients with respect to healthy controls, Qualitative variables are expressed as raw data or either if it was assessed individually or together with percentages, and compared using chi-square tests. Quancomplex I (I1III). Nonetheless, only in three cases of IDC titative data are expressed as mean6S.D., and compared by means of analysis of variance (ANOVA) test. When a been previously reported as polymorphisms [13, 14] .
These values were significantly lower than control values in the Student-Newman-Kreuls post-hoc test.
Discussion
did the values fell below the lower control range (Fig. 1 ). There were no differences between IDC and IC either Impairment of cardiac energy metabolism is considered when comparing results normalised by total protein conto be one of the main causes of IDC [15] . Because centration, or after correcting them by CS activity. myocardium depends heavily on oxidative metabolism, Among the standard parameters to measure myocardial mitochondrial dysfunction might have a primary role in function end-diastolic diameter was found to be the one such disorders. Actually, cardiac involvement has been that better correlated with complex III (r520.02) or found in a great number of mitochondrial diseases, either complex I1III (r520.37) enzymatic activity, although in association with neuromuscular symptoms or, less these inverse relationships did not reach statistical signififrequently, as the main clinical feature [16, 17] . cance (P50.36 and P50.09, respectively).
In the present study, we assessed respiratory chain enzyme activities in heart homogenate from 17 patients suffering end-stage IDC. The main finding was a significant decrease in enzymatic activity of complex III measured either isolated or together with complex I (I1III), independently if expressed as mg of protein or corrected by CS activity. Marin-Garcia et al. [18] also found an abnormal reduction of several mitochondrial enzyme activities in IDC, complex III being the most frequently decreased. Similar findings had been previously found by other authors [19] . Unfortunately, such studies did not include appropriate control groups. On the other hand, two other studies reported increased respiratory complex III activities in IDC [20, 21] , suggesting some sort of mitochondrial compensatory mechanism in heart failure. Those later studies, nevertheless, differed from ours in some methodological aspects. The activity of complex III was not measured directly, but through the activity of complexes I1III and II1III. Furthermore, some patients were not in heart failure class IV of the NYHA classification. When we tried to compare the activity of complex III with the classical parameters to measure heart failure, correlations were in general poor, end-diastolic diameter being the nearest to statistical significance. This could reflect the poor correlations that generally exist between classical measures of cardiac function and heart performance in end-stage cardiac failure. Alternatively and in accordance Although the mean complex III enzymatic values in the IDC group were decreased when compared with noncar
